文献速递慢性肾脏病遗传性与小管间质肾病

开发用于评估常染色体显性多囊肾病患者疼痛与不适的患者报告结局工具

Development of a Patient-Reported Outcomes Tool to Assess Pain and Discomfort in Autosomal Dominant Polycystic Kidney Disease.
PubMed 文献 · Clin J Am Soc Nephrol · 2023-01-02

该研究开发并验证了首个常染色体显性多囊肾病(ADPKD)特异性疼痛量表ADPKD-PDS。定性阶段在18个国家开展46个焦点小组(293人),识别出三种疼痛类型;定量阶段298人完成在线调查、108人完成3-4周后随访。最终量表含20个条目,评估7天内疼痛严重度及对活动干扰,测量模型拟合良好。

要点

  • ADPKD-PDS是首个经系统方法开发并验证的ADPKD特异性疼痛与不适评估工具。
  • 定性研究识别出三种概念上不同的ADPKD相关疼痛:钝性肾痛、锐性肾痛、饱胀/不适。
  • 最终量表含20个条目,评估7天回忆期内疼痛严重度及对活动的干扰。

核心结论

  • ADPKD-PDS是首个用于系统评估ADPKD疼痛与不适的已验证工具。

研究设计与样本

  • 研究分为定性分析阶段与定量分析阶段:定性阶段通过焦点小组和认知访谈开发并完善量表草案。
  • 定量阶段由ADPKD成人完成量表草案及其他患者报告结局工具的在线调查,并在3-4周后进行随访调查。
  • 定量阶段共298名ADPKD成人完成在线调查,其中108名完成随访调查。

主要发现

  • 定性阶段在18个国家开展46个焦点小组,共293名参与者,识别出钝性肾痛、锐性肾痛和饱胀/不适三种概念上不同的ADPKD相关疼痛与不适。
  • 迭代完善后,潜变量测量模型显示拟合非常好,比较拟合指数与非规范拟合指数均为0.99。
  • 条目水平和域水平的心理测量学特征也表现良好。
  • 最终ADPKD-PDS包含20个条目,评估7天回忆期内的疼痛严重度及对活动的干扰。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pain has been identified as a core outcome for individuals with autosomal dominant polycystic kidney disease (ADPKD), but no disease-specific pain assessment has been developed using current development methodology for patient-reported outcomes (PRO) instruments. We developed and validated an ADPKD-specific pain questionnaire: the ADPKD Pain and Discomfort Scale (ADPKD-PDS). METHODS: Conceptual underpinnings were drawn from literature review, concept elicitation, expert consultation, and measurement performance. In the qualitative analysis phase, concepts were elicited from focus groups of adults with ADPKD, and the resulting draft instrument was refined using cognitive debriefing interviews with individuals with ADPKD. For quantitative analysis, adults with ADPKD completed the draft instrument and other PRO tools in an online survey, and a follow-up survey was conducted 3-4 weeks later. Survey responses were analyzed for item-level descriptive statistics, latent model fit statistics, item discrimination, item- and domain-level psychometric statistics, test-retest reliability, responsiveness to change, and convergent validity. RESULTS: In the qualitative phase, 46 focus groups were conducted in 18 countries with 293 participants. Focus groups described three conceptually distinct types of ADPKD-related pain and discomfort (dull kidney pain, sharp kidney pain, and fullness/discomfort). In the quantitative phase, 298 adults with ADPKD completed the online survey, and 108 participants completed the follow-up survey. After iterative refinement of the instrument, latent variable measurement models showed very good fit (comparative fit and nonnormed fit indices both 0.99), as did item- and domain-level psychometric characteristics. The final ADPKD-PDS contains 20 items assessing pain severity and interference with activities over a 7-day recall period. CONCLUSIONS: The ADPKD-PDS is the first validated tool for systematically assessing pain and discomfort in ADPKD.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Oberdhan D, Cole JC, Atkinson MJ, et al. Development of a Patient-Reported Outcomes Tool to Assess Pain and Discomfort in Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2023. PMID: 36754008. doi:10.2215/CJN.0000000000000034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。